ZyVersa Therapeutics Approves Reverse Stock Split
Company Announcements

ZyVersa Therapeutics Approves Reverse Stock Split

An announcement from ZyVersa Therapeutics (ZVSA) is now available.

ZyVersa Therapeutics, Inc. stockholders gathered for a pivotal Special Meeting, voting in favor of a significant Reverse Stock Split, authorizing the board to choose a ratio from 1-for-2 up to 1-for-50. The board has decided on a 1-for-10 ratio, with the split expected to take effect in late April 2024, ushering in a new trading phase for the company on The Nasdaq Capital Market. This move reflects the company’s strategic efforts to adjust its stock structure and market position.

Find detailed analytics on ZVSA stock on TipRanks’ Stock Analysis page.

Related Articles
Sheryl Sheth3 Penny Stocks to Watch Now, 11/7/24
TheFlyZyVersa Therapeutics highlights published data on islet beta cell function
TipRanks Auto-Generated NewsdeskZyVersa Therapeutics’ Shareholder Approvals and Director Elections
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App